
zzso treatment of patients with idiopathic zzso zzso zzso is heavily zzso The controversy is mainly related to the toxicity of the therapy and the variable natural course of the zzso zzso occurs in zzso of zzso The 2012 zzso zzso zzso Global Outcomes zzso Clinical zzso zzso for zzso provides guidance for the treatment of zzso The zzso suggests that zzso therapy should be restricted to patients with zzso syndrome and persistent zzso deteriorating zzso function or severe zzso zzso agents are the preferred therapy because of their proven efficacy in preventing zzso zzso zzso zzso zzso can be used as an alternative although efficacy data on hard zzso end points are zzso In this Review, we zzso the zzso zzso and address remaining areas of zzso Better risk prediction is needed to identify patients who will benefit from zzso therapy, and the optimal timing and duration of this therapy is unknown because most of the zzso controlled trials were performed in low-risk or zzso zzso Alternative therapies, directed at B cells, are under zzso The discovery of zzso type zzso zzso zzso is a major breakthrough and we zzso that in the near future, zzso therapy will enable more individualized treatment of patients with zzso 

